danazol,momelotinib
sierra oncology
['momelotinib', '#mpn', 'momentum', 'mpnsm', '#myelof']
#asco22: phase 3 momentum results show momelotinib is superior to danazol for improving symptoms, spleen size &amp; anemia measures in pts w/ anemic #myelofibrosis who have previously received a jak inhibitor. #hemonc #ascodailynews #mpnsm
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ? endorse.